Beyond aspirin: how glycoprotein inhibitors ease acute coronary syndromes.
Glycoprotein IIb/IIIa receptor inhibitors can improve vessel patency for patients with myocardial infarction and angina. Patients who receive these drugs can be managed more conservatively, without invasive procedures, and may have less risk of recurrent infarction and death.